関連する実験動画
Updated: Jun 28, 2026

07:40
Multi-Modal Home Sleep Monitoring in Older Adults
Published on: January 26, 2019
高齢者の患者における抗高血圧薬の使用時間のパターン. The Cardiovascular Health Study (心臓血管健康に関する研究) によるものです
B M Psaty1, P J Savage, G S Tell
1Department of Medicine, University of Washington, Seattle.
JAMA
|October 20, 1993
まとめ
新規治療を受けた高血圧の発生率は,高齢者の5.2-5.6%であった. 医者は,高血圧治療の利尿薬やベータブロッカーのような古い薬よりも,ますますACE阻害剤やカルシウムチャネルブロッカーのような新しい薬を処方するようになりました.
科学分野:
- ゲロントロジーはゲロントロジーの学科です.
- 心血管医学は,心臓血管医学である.
- 薬理学 薬理学とは
背景:
- 高血圧は,高齢者の一般的な状態です.
- 治療パターンの理解は,高齢者の心臓血管の健康管理に不可欠です.
研究 の 目的:
- 65歳以上で新たに治療を受けた高血圧の発生率を推定する.
- この集団における抗高血圧薬の使用パターンを記述する.
主な方法:
- 5201人のコミュニティに住む高齢者を対象とした前向きなコホート研究 (心臓血管健康研究).
- 標準化されたアンケート,血圧測定,および薬剤在庫をベースラインおよび1年間のフォローアップで収集したデータ.
- 欠落したデータ,フォローアップの喪失,または薬剤に対する高血圧の非徴候を有する参加者の排除.
主要な成果:
- 新規治療を受けた高血圧の年間発生率は,女性では5.2%,男性では5.6%でした.
- 抗高血圧治療の頻度は,1年間でわずか40.7%から41.1% (女性),37.1%から38.2% (男性) に増加した.
- 新たに治療を受けた患者は,以前治療を受けた患者と比較して,利尿剤やベータブロッカーを受ける可能性が低く,カルシウムチャネルブロッカーやアニオテンシン変換酵素阻害剤を受ける可能性が高くなりました.
結論:
- 医者は,高齢者の新しい高血圧治療のために,アンジオテンシン変換酵素阻害剤とカルシウムチャネルブロッカーをますます好みました.
- このシフトは,処方パターンの変化を表し,利尿薬やベータブロッカーから離れています.
- この発見は,高齢者の高血圧管理のための治療戦略の進化を強調しています.
関連する概念動画
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...